SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan
NEOG 6.295+2.1%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kramer who wrote (353)9/6/1999 7:42:00 PM
From: Kramer  Read Replies (1) of 441
 
The weather for harvesting seems to be quite good for agriculture this year so I don't expect to see an extra couple of pennies from vomitoxin or aflatoxin; and as I'd mentioned some time back they are running quite low of Bot B (Tampa supply is available in October), which I think could also cost another couple of cents, although this would be penned up demand; so...considering these two facts and results last year of 13 cents (non-taxed) or 8 cents (adjusted for taxes), I think if we made 9 cents we would be doing damn good this quarter.

I just looked at the analyst estimate, there is only one, and they are way out in left field. The analyst must not know about the tax situation last year. That estimate is irresponsible! I hope no one here is getting fooled by that 16 cent estimate, because IMO that just is not going to happen this quarter.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext